ARCHIVES

Center And Cooperative Group Clinical Trials Approved By NCI

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Contracts Cutback Canceled 7 RFPs

August 8, 1980

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

DeVita Seeks End to Funding For CROS, Reacts With Anger To Charge Of “Central Direction From Washington”

February 20, 1981

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

ACCC Comments On DRGs to Be Review By PROPAC

September 6, 1985